ACM
CMD

AlphaCrest Capital Management’s Cantel Medical Corporation CMD Stock Holding History

AlphaCrest Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,802
Closed -$221K – 1364
2020
Q4 		$221K Sell
2,802
-6,930
-71% -$406K 0.02% 1040
2020
Q3 		$428K Buy
+9,732
New +$479K 0.05% 672
2020
Q2 		– Sell
-9,700
Closed -$348K – 1197
2020
Q1 		$348K Buy
+9,700
New +$552K 0.04% 730
2019
Q4 		– Sell
-5,400
Closed -$404K – 1435
2019
Q3 		$404K Buy
+5,400
New +$458K 0.02% 1013

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AlphaCrest Capital Management's CMD Position: Q1 2021 in Review

AlphaCrest Capital Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 2,802 shares — an estimated $221K sold.

AlphaCrest Capital Management first reported a position in CMD in Q3 2019 and held it in 4 quarters. The position peaked at $428K in Q3 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • AlphaCrest Capital Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • AlphaCrest Capital Management sold 2,802 Cantel Medical Corporation shares in Q1 2021, an estimated $221K.
  • AlphaCrest Capital Management first reported a position in Cantel Medical Corporation in Q3 2019 and held it in 4 quarters.
  • AlphaCrest Capital Management's Cantel Medical Corporation position peaked at $428K in Q3 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on AlphaCrest Capital Management's 13F filing for Q1 2021, filed 13 May 2021.